Clinical Trials on Cirrhotic Ascites in New Zealand

Total 275 results

Institute of Liver and Biliary Sciences, India

Withdrawn

Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.

Refractory Ascites in Children With Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Completed

Efficacy of Combination of Midodrine With Propranolol in Preventing First Bleed in Decompensated Cirrhotics With Severe Ascites.

Decompensated Cirrhosis | Severe Ascites

India
Grifols Therapeutics LLC
Instituto Grifols, S.A.

Active, not recruiting

Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites (PRECIOSA)

Decompensated Cirrhosis and Ascites

United States, Spain, Denmark, Belgium, Germany, Italy, Canada, Hungary, Poland, Bosnia and Herzegovina, Bulgaria, France, Serbia, United Kingdom
Institute of Liver and Biliary Sciences, India

Unknown

Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.

Decompensated Cirrhosis

India
Govind Ballabh Pant Hospital
Jhaver Research Foundation Limited

Completed

Evaluation of Safety & Efficacy of Synbiotic on the Incidence and Recurrence of Spontaneous Bacterial Peritonitis (SBP) in Cirrhotics

Cirrhosis With Ascites

India
Institute of Liver and Biliary Sciences, India

Unknown

Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites

Liver Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites

Liver Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Recruiting

Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.

Liver Cirrhosis

India
Govind Ballabh Pant Hospital

Suspended

Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis

Cirrhosis | Ascites

India
Institute of Liver and Biliary Sciences, India

Unknown

Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.

Liver Cirrhoses

India
Weill Medical College of Cornell University

Withdrawn

Effect of Large Volume Paracentesis on Fatigue in Cirrhosis

Fatigue | Cirrhosis | Ascites

United States
Yale University
Boehringer Ingelheim

Recruiting

Empagliflozin in Patients With Cirrhosis and Ascites (EMPA Liver)

Liver Failure | Cirrhosis

United States
Sanofi

Completed

Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) (CATS)

Liver Cirrhosis | Ascites

United States, France, Brazil, Poland, Romania, Russian Federation, Italy, Netherlands, Portugal, Sweden, Belgium, Argentina, Croatia, Denmark, Hungary, Israel, Spain, Chile, Canada, United Kingdom, Australia
Institute of Liver and Biliary Sciences, India

Unknown

Safety and Efficacy of Small Frequent Paracentesis Using an Indwelling CAtheter Compared With Repeated Large Volume Paracentesis in Cirrhotic Patients With REfractory Ascites

Liver Cirrhosis

India
Sanofi

Completed

Satavaptan Dose-Ranging Study in the Prevention of Ascites (SPA)

Liver Cirrhosis | Ascites

France, Germany, Italy, Spain, Taiwan, Belgium, Czech Republic, Argentina, Croatia, Canada, Australia
Sanofi

Completed

Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites (Normo~CAT)

Liver Cirrhosis | Ascites

France, Romania, Germany, Spain, Belgium, Czech Republic, Argentina, Croatia, Hungary, Italy, Canada, Australia
Institute of Liver and Biliary Sciences, India

Recruiting

Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices

Liver Cirrhosis

India
Sanofi

Completed

Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites (Hypo~CAT)

Liver Cirrhosis | Ascites

United States, France, Romania, Germany, Italy, Spain, Belgium, Czech Republic, Argentina, Croatia, Hungary, Canada, Australia
Institute of Liver and Biliary Sciences, India

Withdrawn

To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.

Cirrhosis

India
NYU Langone Health

Withdrawn

The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis

Hepatic Encephalopathy | Fatigue | Cirrhosis | Ascites

United States
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals Australia Pty Ltd

Completed

Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

United States, Australia, New Zealand
Memorial Sloan Kettering Cancer Center

Completed

Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites

Ascites

United States
Neovii Biotech
Fresenius Biotech North America

Completed

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Malignant Ascites

United States
Arena Pharmaceuticals

Terminated

Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis

Primary Biliary Cholangitis

United States, Australia, New Zealand
Ocelot Bio, Inc

Completed

A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury

Cirrhosis | Ascites | Acute Kidney Injury | Hepatorenal Syndrome

United States, Canada
Argon Medical Devices
Avania

Terminated

Achieving Portal Access With Scorpion Post-Approval Study (APASS)

Liver Diseases | Vascular Diseases | Portal Hypertension | Ascites Hepatic | Hydrothorax

United States
Gilead Sciences

Completed

Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation

Hepatitis C | Cirrhosis | Portal Hypertension | With or Without Liver Decompensation

United States, Spain, New Zealand, Australia, France
Institute of Liver and Biliary Sciences, India

Recruiting

Rotational Thromboelastometry Versus Conventional Haemostatic Tests in Children With Decompensated Cirrhosis Undergoing Invasive Procedures.

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Completed

To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.

Cirrhosis, Liver

India
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Incidence & Predictive Factors of Recompensation in Children With Decompensated Cirrhosis as Per the Baveno VII Criteria

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Withdrawn

Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis

Advanced Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Completed

A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Recruiting

The Natural History and Prognostic Factors of Compensated Cirrhosis.

Compensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decompensation of Cirrhosis

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Withdrawn

Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.

NASH Related Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Terminated

To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis

HCV Related Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Not yet recruiting

To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis

Decompensated Cirrhosis | Compensated Cirrhosis

India
Danny Lascano

Completed

Cirrhotics Undergoing General Surgery

Cirrhosis, Liver

United States
Institute of Liver and Biliary Sciences, India

Withdrawn

Impact of Acute Decompensation in Patients of Cirrhosis With or Without Prior Decompensation

Acute Decompensation in Liver Cirrhosis

India
New Mexico Cancer Care Alliance

Completed

A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes

Supportive | Ill-defined Sites

United States
Institute of Liver and Biliary Sciences, India

Completed

To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.

Decompensated Cirrhosis

India
Sir Ganga Ram Hospital

Completed

To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis

Cirrhosis

India
Sir Ganga Ram Hospital

Unknown

Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver Cirrhosis

Cirrhosis

India
Dr. Ashish Kumar

Completed

Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation

Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Completed

Rotational Thromboelastometry Guided Blood Component Use in Children With Cirrhosis Undergoing Invasive Procedures: A Randomized Controlled Trial

Cirrhosis, Liver

India
Institute of Liver and Biliary Sciences, India

Completed

Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation

Cirrhosis, Liver

India
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Rotational Thromboelastometry [ROTEM] vs Thromboelastography [TEG] Guided Blood Component Use in Patients With Cirrhosis of Liver With Non-variceal Bleeding.

Liver Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Completed

Influence of Shunt Occlusion on Organ Functions in Hyperammonemic Patients With Cirrhosis Having Porto-systemic Shunt.

Cirrhosis

India

3

Subscribe